C. Xiao

发表

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Saijuan Chen, Lanping Xu, Xiao Li, 2016, Tumor Biology.

Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients

Chun-kang Chang, C. Xiao, Youshan Zhao, 2021, Frontiers in Oncology.

High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Feng Xu, 2013, Tumor Biology.

Analysis of the influencing factors related to liver and cardiac iron overload in MDS patients detected by MRI in the real world

Yan Jia, Xiao Li, Chun-kang Chang, 2021, Hematology.

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2021, Clinical Epigenetics.

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Xiao Li, Chun-kang Chang, Juan Guo, 2017, American journal of translational research.

TP53 mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, British journal of haematology.

Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, Hematology.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

[Yield of CD34(+) cells in graft can be increased significantly by G-CSF used at appropriate time after chemotherapy for AutoPBSCT].

Hong Liu, Xiao Li, Chun-kang Chang, 2011, Zhongguo shi yan xue ye xue za zhi.

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Wenhui Shi, 2016, Journal of Translational Medicine.

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2017, Leukemia & lymphoma.

[Research advances of hepcidin expression and its regulation mechanism].

Xiao Li, Chun-kang Chang, C. Xiao, 2012, Zhongguo shi yan xue ye xue za zhi.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Qi He, Feng Xu, Lingyun Wu, 2016, Journal of Translational Medicine.

The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS

Chun-kang Chang, Lu-xi Song, C. Xiao, 2022, Frontiers in Oncology.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Cheng-Long Hu, Juan Guo, Lingyun Wu, 2023, Science Advances.

NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy

Xiao Li, Chun-kang Chang, Juan Guo, 2020, British Journal of Haematology.